Clinical Trial Update: PSMA PET/CT for Assessment of Recurrent Prostate Cancer

View source ↗

Summary

Clinical trial update for PSMA PET/CT in assessing recurrent prostate cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Prostatic Neoplasms, Prostate Cancer | Status: ACTIVE_NOT_RECRUITING